In the circulation, IGF2R expressing lymphocytes were detected both in healthy donors (mean 18.6 ± 7.6%) and breast cancer patients (mean 22.7 ± 12.4) with high PD-1 expression (Figure 5I-J and Figure S5C). Here, IGF2R is linked to breast carcinoma.